Funder: National Institutes of Health (NIH)
Due Dates: March 25, 2026 (anticipated)
Funding Amounts: $30,000,000 total; approximately 2 awards expected; UM2 Cooperative Agreement
Summary: Supports the development of a clinical trials network for high-priority HIV research in pediatric, adolescent, young adult, and maternal populations.
Key Information: This is a forecasted opportunity; applications are not being accepted yet.